Adial Pharmaceuticals Announces Planned Expansion of Lead Asset AD04 into Opioid Addiction Including Synthetic Opioids Such as Fentanyl
Stock Information for Adial Pharmaceuticals Inc
Loading
Please wait while we load your information from QuoteMedia.